Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
100%
Cardiovascular Outcomes
100%
Saxagliptin
100%
Placebo Groups
40%
Confidence Interval
40%
Hazard Ratio
40%
Cardiovascular Mortality
20%
Heart Failure
20%
Myocardial Infarction
20%
Chronic Pancreatitis
20%
Acute Pancreatitis
20%
Kaplan-Meier Estimator
20%
Antihyperglycemic
20%
Hospitalization
10%
Placebo
10%
Patients with Diabetes
10%
Cardiovascular Risk
10%
Ischemic Stroke
10%
Cardiovascular Events
10%
Glycemic Control
10%
Heart Failure Hospitalization
10%
Ischemic Events
10%
Stable Angina
10%
Dipeptidyl peptidase-4 (DPP-4)
10%
Dipeptidyl peptidase-4 Inhibition
10%
Coronary Revascularization
10%
Myocardial Ischemia
10%
Online Treatment
10%
Non-inferiority
10%
Coronary Heart
10%
Cardiovascular Safety
10%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Saxagliptin
100%
Placebo
50%
Heart Failure
30%
Heart Infarction
20%
Acute Pancreatitis
20%
Chronic Pancreatitis
20%
Cardiovascular Risk
10%
Brain Ischemia
10%
Unstable Angina Pectoris
10%
Dipeptidyl Peptidase IV Inhibitor
10%
Dipeptidyl Peptidase IV
10%